Huadong Medicine Chairman Proposes Interim Dividend Plan for 2026

Stock News07-20

An announcement from Huadong Medicine Co.,Ltd. (SZSE: 000963) reveals a proposal by the company's Chairman, Mr. Lv Liang.

The proposal, made under the authority granted by the 2025 annual general meeting of shareholders held on May 20, 2026, and subject to compliance with relevant laws and the company's articles of association, concerns an interim profit distribution plan for 2026.

It is suggested to distribute cash dividends to all shareholders at a rate of 3.50 yuan (including tax) per 10 shares, based on the total share capital on the record date for this future distribution.

The plan does not include bonus share issues or capital reserve conversions into share capital.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment